Evaluation of 3–5 months’ add-on therapy with montelukast in patients with non-controlled asthma in Austria: the STAR open-label, real-world, observational study

By Schlick Werner   Pohl Wolfgang   Pfeiffer Karl P.   Aigner Kurt   Forche Günter   Kneussl Meinhard   Zwick Hartmut  

Current Medical Research and Opinion, Vol. 26, Iss. 3, 2010-03 ,pp. : 561-570

Informa Healthcare

Access to resources Recommend Favorite

Montelukast in the treatment of asthma and allergic rhinitis

By Neighbour Helen   McIvor Andrew  

Clinical Practice, Vol. 10, Iss. 3, 2013-05 ,pp. : 257-263

Future Medicine

Access to resources Recommend Favorite

The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis

By Philip George   Nayak Anjuli S.   Berger William E.   Leynadier Francisque   Vrijens France   Dass S. Balachandra   Reiss Theodore F.  

Current Medical Research and Opinion, Vol. 20, Iss. 10, 2004-10 ,pp. : 1549-1558

Informa Healthcare

Access to resources Recommend Favorite

Efficacy of add-on montelukast in patients with non-controlled asthma: a Belgian open-label study*

By Korn Dana   Brande Paul Van den   Potvin Emmanuel   Dramaix Michèle   Herbots Ella   Peché Rudi  

Current Medical Research and Opinion, Vol. 25, Iss. 2, 2009-02 ,pp. : 489-497

Informa Healthcare

Access to resources Recommend Favorite

Comparative Effects of Desloratadine versus Montelukast on Asthma Symptoms and Use of β₂-Agonists in Patients with Seasonal Allergic Rhinitis and Asthma

By  

International Archives of Allergy and Immunology, Vol. 130, Iss. 4, 2003-05 ,pp. : 307-313

Karger

Access to resources Recommend Favorite